Aakaar Medical Technologies IPO - Day 3 Subscription at 2.28 Times

Aakaar Medical Technologies' initial public offering (IPO) has demonstrated modest investor demand through its three-day subscription period, with Aakaar Medical Technologies' stock price band set at ₹68 to ₹72 per share and Aakaar Medical Technologies' share price expected to reflect modest market reception. The ₹27.00 crore IPO has witnessed steady progress, with subscription rates opening at 0.37 times on day one, improving to 0.68 times on day two, and reaching modest 2.28 times by 5:20:01 PM on the final day, demonstrating modest investor interest in this aesthetic medical company incorporated in June 2013, offers diverse selection of specialized cosmetic products and devices, deals in specialty products for dermatologists, plastic surgeons, aesthetic physicians, cosmetologists, product portfolio encompasses both own brands consisting of domestically manufactured products and internationally produced devices, and imported brands sourced from countries such as South Korea, Spain, Italy, and Austria.

Aakaar Medical Technologies IPO qualified institutional buyers segment leads with modest 3.51 times subscription, while retail investors demonstrate modest participation at 1.93 times and non-institutional investors show modest interest at 1.48 times, reflecting moderate investor confidence in this company with branches across India with team of 90 trained sales and service engineers serving thousands of satisfied customers, sells products to states of Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu, offers product range including homecare and professional skin care, injectable and contouring, professional skincare products, hair growth serum and tablets, medifacial kit, devices for urinary incontinence, tattoo removal, pigmentation and skin rejuvenation devices, laser hair reduction devices, hair transplant device, promoters Dilip Ramesh Meswani and Bindi Dilip Meswani holding 91.11% pre-issue shareholding, raised ₹7.68 crores from anchor investors.

Aakaar Medical Technologies IPO subscription reached a modest 2.28 times on the final day, led by QIB (3.51x), Retail (1.93x), and NII (1.48x). Total applications reached 1,637.

Subscription Status of Aakaar Medical Technologies IPO:

Here are the subscription details for Aakaar Medical Technologies IPO as of Day 3 (June 24, 2025, 5:20:01 PM):

Key Highlights - Day 3:

• Overall subscription reaching a modest 2.28 times, an improvement from day two's 0.68 times
• QIB segment leading with modest demand at 3.51 times, a significant jump from day two's 0.33 times
• Retail segment showing modest participation at 1.93 times, improvement from day two's 0.89 times
• NII segment demonstrating modest interest at 1.48 times, an increase from day two's 0.66 times
• Total applications reached 1,637, indicating limited investor participation
• The cumulative bid amount reached ₹41.046 crores against the issue size of ₹27.00 crores
• Final day demonstrating modest confidence in the aesthetic medical devices sector
• All investor categories are showing limited oversubscription, reflecting cautious market reception

Aakaar Medical Technologies IPO - Day 2 Subscription at 0.68 Times

Key Highlights - Day 2:

• Overall subscription improving to 0.68 times, progress from day one's 0.37 times
• Retail segment showing improvement at 0.89 times, an increase from day one's 0.31 times
• NII segment showing slight improvement at 0.66 times, an increase from day one's 0.59 times
• QIB segment maintains a consistent low interest at 0.33 times, the same as day one

Aakaar Medical Technologies IPO - Day 1 Subscription at 0.37 Times

Key Highlights - Day 1:

• Overall subscription opening weak at 0.37 times, showing cautious initial investor interest
• NII segment leading with modest early participation at 0.59 times on day one
• QIB segment showing limited initial interest at 0.33 times, indicating institutional caution
• Retail segment showing weak early approach at 0.31 times
• Opening day demonstrates reserved initial engagement

About Aakaar Medical Technologies IPO

Incorporated in June 2013, Aakaar Medical Technologies Limited is an aesthetic medical company that offers a diverse selection of specialised cosmetic products and devices. The company deals in speciality products for Dermatologists, Plastic Surgeons, Aesthetic Physicians, and Cosmetologists.

Financial performance shows strong growth with revenue increasing 33% from ₹46.27 crores in FY2024 to ₹61.76 crores in FY2025, while profit after tax surged 110% from ₹2.87 crores to ₹6.04 crores. The company maintains good profitability metrics with 21.02% ROCE, 33.81% RoNW, operates with a moderate debt-to-equity ratio of 0.98, and has a market capitalisation of ₹102.04 crores. Post-IPO P/E ratio of 16.9x appears reasonable for a growing aesthetic medical company.

Highlights of the Aakaar Medical Technologies IPO:

• IPO type: Book Building IPO
• IPO size: ₹27.00 crores
• Fresh Issue: 37.50 lakh shares
• Face value: ₹10 per share
• Issue price band: ₹68 to ₹72 per share
• Lot size: 1,600 shares
• Minimum investment for retail investors: ₹1,15,200 (1 lot, 1,600 shares)
• Minimum investment for HNI: ₹2,30,400 (2 lots, 3,200 shares)
• Anchor investor allocation: ₹7.68 crores
• Book-running lead manager: Indorient Financial Services Ltd
• Registrar: Bigshare Services Pvt Ltd
• Market maker: Alacrity Securities Ltd
• Listing at: NSE SME
• IPO opens: June 20, 2025
• IPO closes: June 24, 2025
• Allotment date: June 25, 2025
• Listing date: June 27, 2025